Terms: = Prostate cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Diagnosis
19 results:
1. Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis.
Lim CS; Abreu-Gomez J; Thornhill R; James N; Al Kindi A; Lim AS; Schieda N
Abdom Radiol (NY); 2021 Dec; 46(12):5647-5658. PubMed ID: 34467426
[TBL] [Abstract] [Full Text] [Related]
2. Association of prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk prostate cancer With Active Surveillance.
Nelson TJ; Javier-DesLoges J; Deka R; Courtney PT; Nalawade V; Mell L; Murphy J; Parsons JK; Rose BS
JAMA Netw Open; 2021 May; 4(5):e219452. PubMed ID: 33999164
[TBL] [Abstract] [Full Text] [Related]
3. cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract] [Full Text] [Related]
4. Tobacco smoking and death from prostate cancer in US veterans.
Riviere P; Kumar A; Luterstein E; Vitzthum LK; Nalawade V; Sarkar RR; Bryant AK; Einck JP; Mundt AJ; Murphy JD; Rose BS
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):252-259. PubMed ID: 31624316
[TBL] [Abstract] [Full Text] [Related]
5. Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer.
Gupta N; Bivalacqua TJ; Han M; Gorin MA; Challacombe BJ; Partin AW; Mamawala MK
BJU Int; 2019 Aug; 124(2):268-274. PubMed ID: 30570825
[TBL] [Abstract] [Full Text] [Related]
6. Impact of Pelvic Radiation Therapy on Inflatable Penile Prosthesis Reoperation Rates.
Golan R; Patel NA; Sun T; Barbieri CE; Sedrakyan A; Kashanian JA
J Sex Med; 2018 Nov; 15(11):1653-1658. PubMed ID: 30415817
[TBL] [Abstract] [Full Text] [Related]
7. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract] [Full Text] [Related]
8. A Comparative Analysis of Survival and Funding Discrepancies in cancers With High Mortality.
Hall BR; Cannon A; Atri P; Wichman CS; Smith LM; Kumar S; Batra SK; Wang H; Ganti AK; Sasson AR; Are C
Ann Surg; 2020 Feb; 271(2):296-302. PubMed ID: 30188400
[TBL] [Abstract] [Full Text] [Related]
9. Establishment of Korean prostate cancer database by the Korean Urological Oncology Society.
Ahn H; Kim HJ; Jeon SS; Kwak C; Sung GT; Kwon TG; Park JY; Paick SH
Investig Clin Urol; 2017 Nov; 58(6):434-439. PubMed ID: 29124243
[TBL] [Abstract] [Full Text] [Related]
10. Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer.
Venderbos LD; Roobol MJ; Bangma CH; van den Bergh RC; Bokhorst LP; Nieboer D; Godtman R; Hugosson J; van der Kwast T; Steyerberg EW
World J Urol; 2016 Feb; 34(2):253-60. PubMed ID: 26160006
[TBL] [Abstract] [Full Text] [Related]
11. Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care.
Samuel CA; Landrum MB; McNeil BJ; Bozeman SR; Williams CD; Keating NL
Am J Public Health; 2014 Sep; 104 Suppl 4(Suppl 4):S562-71. PubMed ID: 25100422
[TBL] [Abstract] [Full Text] [Related]
12. Association between prostate cancer and urinary calculi: a population-based study.
Chung SD; Liu SP; Lin HC
PLoS One; 2013; 8(2):e57743. PubMed ID: 23451265
[TBL] [Abstract] [Full Text] [Related]
13. Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database.
White WM; Sadetsky N; Waters WB; Carroll PR; Litwin MS
J Urol; 2008 Dec; 180(6):2409-13; discussion 2414. PubMed ID: 18930270
[TBL] [Abstract] [Full Text] [Related]
14. Survival associated with treatment vs observation of localized prostate cancer in elderly men.
Wong YN; Mitra N; Hudes G; Localio R; Schwartz JS; Wan F; Montagnet C; Armstrong K
JAMA; 2006 Dec; 296(22):2683-93. PubMed ID: 17164454
[TBL] [Abstract] [Full Text] [Related]
15. Recognition of malignant processes with neural nets from ESR spectra of serum albumin.
Seidel P; Gurachevsky A; Muravsky V; Schnurr K; Seibt G; Matthes G
Z Med Phys; 2005; 15(4):265-72. PubMed ID: 16422355
[TBL] [Abstract] [Full Text] [Related]
16. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.
Latini DM; Elkin EP; Cooperberg MR; Sadetsky N; Duchane J; Carroll PR
Cancer; 2006 Feb; 106(4):789-95. PubMed ID: 16400651
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of bone alkaline phosphatase as a marker for the diagnosis of osteoporosis in men under androgen ablation.
Morote J; Trilla E; Esquena S; Abascal JM; Segura RM; Catalan R; Encabo G; Reventós J
Int J Biol Markers; 2003; 18(4):290-4. PubMed ID: 14756545
[TBL] [Abstract] [Full Text] [Related]
18. Diabetes and the risk of prostate cancer.
Tavani A; Gallus S; Bosetti C; Tzonou A; Lagiou P; Negri E; Trichopoulos D; La Vecchia C
Eur J Cancer Prev; 2002 Apr; 11(2):125-8. PubMed ID: 11984129
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assays.
Junker R; Brandt B; Zechel C; Assmann G
Clin Chem; 1997 Sep; 43(9):1588-94. PubMed ID: 9299938
[TBL] [Abstract] [Full Text] [Related]
